Table 1. SNPs associated with risk of relapse discovered in both Danish and German cohorts.
SNP |
NOPHO ALL92 and 2000 |
BFM ALL2000 |
Combined cohorts |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rs ID | Gene | Cons | P-value | OR | MAF relapse | MAF CR | P-value | OR | MAF relapse | MAF CR | MAF relapse | MAF CR | P-value | OR |
Rs3216144 | MMP7 | Regulatory | 4.0E−04 | 0.14 | 0.05 | 0.26 | 2.0E−03 | 0.32 | 0.09 | 0.24 | 0.07 | 0.24 | 6.0E−06 | 0.26 |
Rs10502001 | MMP7 | NSC | 4.0E−04 | 0.14 | 0.05 | 0.25 | 2.0E−03 | 0.32 | 0.09 | 0.24 | 0.08 | 0.24 | 6.0E−06 | 0.26 |
Rs10795242 | AKR1C3 | Intronic | 8.6E−03 | 2.13 | 0.31 | 0.17 | 3.7E−02 | 1.85 | 0.24 | 0.15 | 0.27 | 0.16 | 5.0E−04 | 2.01 |
Rs28730837 | MPO | NSC | 4.7E−02 | 4.26 | 0.06 | 0.02 | 1.5E−02 | 3.19 | 0.06 | 0.02 | 0.06 | 0.02 | 1.0E−03 | 3.60 |
Rs6139873 | CHGB | NSC | 4.0E−03 | 19.56 | 0.11 | 0.01 | 3.9E−02 | 3.50 | 0.04 | 0.01 | 0.06 | 0.01 | 1.1E−03 | 5.75 |
Rs1293945 | ESR1 | Regulatory | 2.0E−02 | 1.86 | 0.59 | 0.43 | 2.6E−02 | 1.95 | 0.59 | 0.42 | 0.59 | 0.43 | 1.3E−03 | 1.91 |
Rs3763156 | LMNB1 | Intronic | 2.0E−02 | 3.06 | 0.19 | 0.07 | 4.0E−02 | 2.15 | 0.15 | 0.07 | 0.16 | 0.07 | 1.6E−03 | 2.43 |
Rs55684978 | HTR3D | SC | 1.6E−02 | 8.08 | 0.07 | 0.01 | 3.2E−02 | 3.85 | 0.04 | 0.01 | 0.05 | 0.01 | 1.8E−03 | 4.88 |
Rs1058047 | TMED7 | Splice site | 1.3E−02 | 8.64 | 0.08 | 0.01 | 3.9E−02 | 3.20 | 0.05 | 0.02 | 0.06 | 0.02 | 3.1E−03 | 3.98 |
Rs35721373 | DYSF | SC | 1.5E−02 | 4.89 | 0.13 | 0.03 | 3.1E−02 | 2.52 | 0.09 | 0.04 | 0.10 | 0.04 | 3.3E−03 | 2.96 |
Rs6601899 | AKR1C3 | Intronic | 3.9E−02 | 1.77 | 0.31 | 0.20 | 3.6E−02 | 1.80 | 0.24 | 0.15 | 0.27 | 0.17 | 3.3E−03 | 1.84 |
Abbreviations: cons, consequence of the SNP on its transcript from Ensembl Variant Effect Predictor; MAF CR, minor allele frequency in complete remission patients; MAF relapse, minor allele frequency in relapse patients; NSC, nonsynonymous coding; OR, odds ratio; P-value, adaptive permutation P-values; SC, synonymous coding.